May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
IGF-I as a Modulating Factor for Bullous Keratopathy Corneas
Author Affiliations & Notes
  • M.C. Kenney
    Dept. Ophthalmology, University of California Irvine, Irvine, CA, United States
  • N.C. Zorapapel
    Ophthalmology, University of California Irvine, Irvine, CA, United States
  • A.V. Ljubimov
    Dept. Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States
  • S.R. Atilano
    Dept. Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States
  • D.J. Brown
    Dept. Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, United States
  • Footnotes
    Commercial Relationships  M.C. Kenney, None; N.C. Zorapapel, None; A.V. Ljubimov, None; S.R. Atilano, None; D.J. Brown, None.
  • Footnotes
    Support  NIH Grant EY10836
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 919. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.C. Kenney, N.C. Zorapapel, A.V. Ljubimov, S.R. Atilano, D.J. Brown; IGF-I as a Modulating Factor for Bullous Keratopathy Corneas . Invest. Ophthalmol. Vis. Sci. 2003;44(13):919.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Pseudophakic bullous keratopathy (PBK) is a leading indication for corneal transplantation. PBK corneas have increased levels of tenascin-C (TN-C), fibrillin-1 (Fib-1), matrix metalloproteinase-2 (MMP-2), infiltrating macrophages/inflammatory cells but lack myofibroblasts. Previous studies showed PBK corneas have increased levels of insulin-like growth factor-I (IGF-I), bone morphogenetic protein-4 (BMP-4) and transforming growth factor-ß (TGF-ß). The current study was conducted to determine whether any of these exogenous growth factors could elicit a PBK-like response from cells in vitro. Methods: Normal and PBK stromal keratocyte cultures were treated with IGF-I, BMP-4, or TGF-ß. Western blotting, Northern blotting, gelatinase zymography and activity assays were performed. Results: IGF-I increased the accumulation of TN-C protein, Fib-1 protein and RNA, MMPs (gelatinases inhibited by EDTA) and had no effect on α-SMA (marker for myofibroblasts). BMP-4 had no effect on TN-C, Fib-1 or α-SMA but increased MMPs. TGF-ß increased TN-C protein, Fib-1 protein and RNA, had little effect on MMPs but also induced α-SMA. Conclusions: Using an in vitro system, exogenous IGF-I most closely elicited responses similar to the parameters found in human PBK corneas, i.e., accumulations of TN-C, Fib-1, and MMPs all in absence of myofibroblasts. These data suggest that IGF-I may be the important modulating factor for this disorder. Support: NIH EY10836; Schoellerman Charitable Foundation; Discovery Fund for Eye Research; Skirball Foundation, and Guenther Foundation. NONE

Keywords: cornea: basic science • cornea: stroma and keratocytes • growth factors/growth factor receptors 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×